In the BioHarmony Drug Report Database
Gadobutrol
Gadavist (gadobutrol) is a small molecule pharmaceutical. Gadobutrol was first approved as Gadavist on 2011-03-14. Gadavist’s patent is valid until 2021-11-09 (FDA).
Trade Name
|
Gadavist |
|---|---|
Common Name
|
gadobutrol |
ChEMBL ID
|
CHEMBL2218860 |
Indication
|
|
Drug Class
|
Gadolinium derivatives (principally for diagnostic use) |
Image (chem structure or protein)